Mr James Frith

Medicine supply chains are complicated, global and highly regulated. On the point that the hon. Gentleman makes about price and prospective profiteering, I would be very happy to speak with him in mor

My hon. Friend makes a really important point. Ensuring sustainable supply for so sensitive a medicine to address epilepsy is uppermost in my mind. It is a live situation, I am working at pace with of

The first nation status that we have with US pharma is an advance on the usual relationships—it comes with huge benefits—but I should be happy to take away more specific concerns that the hon. Gentlem

I thank the hon. Member for his excellent question. The Government are protecting choice in the Health Bill. It is a chance also to affirm the independent sector and the vital role that it plays. Opto

I recognise that too many of my hon. Friend’s constituents are struggling to secure an NHS dentist, despite the improvements that have already been made. Responsibility for commissioning dentistry sit

It is an honour to have the opportunity to respond to the champion for Harlow. It also presents me with the opportunity to make clear that, contrary to reports over the summer, should men suspect that